Why This Swedish Pe Firm Is Willing To Bet $5B In India This Year
Swedish private equity firm EQT will seek out healthcare and financial services companies apart from its traditional focus on IT services firms in India.
Researchers Say 'loss Avoidance' Is All The Rage In Private Equity
Private equity (PE) is known as a "high-risk, high-return" asset class. But as risk-averse institutional investors continue to up their stake in PE, private fund managers are expected to provide metrics that characterize the riskiness of their portfolios. Yet the lack of observable prices makes traditional measures of risk (such as standard deviation of periodic investment returns) entirely unsuitable.
Kkr Co-ceos Following Berkshire Model With Private Equity Bets | Wealth Management
KKR is betting on gains in private equity as some of its peers move away from buyouts on the belief that the business is at scale and the biggest returns are in the past.
Buyout Giant Cvc May Seek More Than $1.45B In Amsterdam Ipo | The Straits Times
CVC manages €186 billion of assets and owns stakes in companies like Breitling and Lipton Teas. :
LONDON – CVC Capital Partners is set to revive plans for an initial public offering (IPO) in Amsterdam and may seek to raise between about €1 billion (S$1.45 billion) and €1.5 billion, according to people familiar with the matter. It potentially paves the way for other private equity firms to go public.
Lps Push Gps To Tie Fund Fees To Impact Goals | Portfolio For The Future
By David Stevenson, a London-based financial writer for PitchBook News, covering private equity. When KKR closed its sixth European buyout vehicle on $8 billion, it did so with around $1 billion of its own capital contributing to the fund corpus. The New York-based firm is one of many GPs pumping more of their own money into their funds.
Jpmorgan Leads Underwriters On A Piece Of The Deal To Buy Out The Controlling Investor In Wwe, Ultimate Fighting Championship
Banks and direct lenders are going head-to-head to finance deals. :
Silver Lake Management has lined up as much as $8.5 billion of debt financing for its buyout of Endeavor Group Holdings Inc., the talent agency and controlling investor in WWE and the Ultimate Fighting Championship. JPMorgan Chase & Co. is leading underwriters on a portion of the financing structured as a leveraged loan, according to people with knowledge of the matter. The makeup and amount of debt could still change, said the people, who asked not to be named because they’re not authorized to speak publicly.
Exclusive-israeli Insurance Software Maker Sapiens Explores Sale, Sources Say - Cna
:Sapiens International, an Israel-headquartered insurance software firm with a market value of nearly $2 billion, is exploring options that include a potential sale, according to people familiar with the matter. Sapiens is working with investment bank William Blair to gauge interest from potential buyers that could include private equity firms, the sources said. Sapiens started exploring a sale after attracting takeover interest last summer and put its plans on hold after the conflict between Israel and Hamas rocked the region, one of the sources said. Sapiens revived its efforts to sell itself a few weeks ago, according to the sources.
Regulators Force Microsoft To Unbundle Teams From Office - The New York Times
The tech giant is unbundling Teams from its Office software suite, as it faces mounting scrutiny on both sides of the Atlantic.
Cytokinetics Incorporated: Buyout Speculation Persists (nasdaq:cytk)
Shares of heart disease concern Cytokinetics, Incorporated (NASDAQ:CYTK) continued to be whipsawed by off and on-again buyout speculation. This week it was speculated that Eli Lilly (LLY) might be an interested party. Novartis (NVS), Johnson & Johnson (JNJ), Amgen (AMGN) and AstraZeneca (AZN) have all been linked at one time as potential suitors for this midcap concern in recent months. This most recent buyout chatter came two weeks after the CEO at Cytokinetics stated the company was perfectly comfortable remaining a standalone entity, which took some wind out of the sales of the stock.
Take-private Deal Or Not, Nuvei Is Attractive (nasdaq:nvei) | Seeking Alpha
I have been closely following the global Fintech sector for a few years. Expanding my horizons beyond just the U.S., I decided to invest in StoneCo Ltd. (STNE) a couple of years ago with the company continuing to make steady progress in Brazil, one of the hotspots for Fintech. Nuvei Corporation (NASDAQ:NVEI), a small yet profitable payment processing company based out of Montreal, Canada, caught my eye last week and I wanted to dig deeper to understand the dynamics behind the company. Nuvei is backed by Ryan Reynolds who invested an undisclosed amount in the company last year.